stars 1 stars 2 stars 3

GlycoSyn is a world-leading CDMO in complex chemistry, with deep expertise in polymers, lipids, carbohydrates, and other challenging molecular structures. For over 20 years, we’ve been committed to advancing the development of life-changing medicines. Our proven expertise in chemical route design, analytical and process development, and current Good Manufacturing Practice (cGMP) enables us to support your product journey from early concept through to clinical supply. We turn complex chemistry into commercial success —at any scale. Our high-trust, transparent partnerships span from NASDAQ-listed pharmaceutical companies to fast-growing biotech start-ups. With a distinguished track record in drug development and regulatory submission, we help de-risk your Chemistry, Manufacturing, and Controls (CMC) programs. Our team of friendly experts combines scientific excellence with a deep understanding of regulatory requirements. We’re committed to safeguarding your product’s quality—and your intellectual property—every step of the way.

GlycoSyn Questions

The GlycoSyn annual revenue was $10.7 million in 2026.

Anushka Jayasuriya is the Director, Business Development and Partnerships of GlycoSyn.

10 people are employed at GlycoSyn.

GlycoSyn is based in Lower Hutt, Wellington.

The NAICS codes for GlycoSyn are [31, 3254, 32, 325, 311, 32541].

The SIC codes for GlycoSyn are [202, 283, 20, 28].

Top GlycoSyn Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users